SECRETED POLYPEPTIDE SPECIES REDUCED IN CARDIOVASCULAR DISORDERS
The invention discloses human secreted potypeptides that circulate at a decreased level in the plasma of patients with cardiovascular disorders. The invention also provides methods of using compositions including the polypeptides, polynucleotides encoding them, and antibodies specific for these poly...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NIKNEJAD, ANNE MAHE, EVE ROSE, KEITH BOUGUELERET, LYDIE ARGOUD-PUY, GUILAINE CUSIN, ISABELLE REFFAS, SAMIA BEDERR, NASSIMA SAUDRAIS, CEDRIC |
| description | The invention discloses human secreted potypeptides that circulate at a decreased level in the plasma of patients with cardiovascular disorders. The invention also provides methods of using compositions including the polypeptides, polynucleotides encoding them, and antibodies specific for these polypeptides, for diagnosis, prognosis, and for drug development.
La présente invention concerne des polypeptides sécrétés humains qui circulent à un niveau réduit dans le plasma de patients atteints d'affections cardio-vasculaires. Cette invention se rapporte également à des méthodes d'utilisation de compositions comprenant les polypeptides, les polynucléotides qui les codent et les anticorps spécifiques contre ces polypeptides à des fins de diagnostic, de pronostic et pour la mise au point de médicaments. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2005014635A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2005014635A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2005014635A23</originalsourceid><addsrcrecordid>eNrjZHAIdnUOcg1xdVEI8PeJDHANCPF0cVUIDnB19nQNVghydQl1Bsp5-ik4Owa5ePqHOQY7h_o4Bim4eAb7B7m4BgXzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAwNTA0MTM2NTRyNj4lQBAHTHK8w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SECRETED POLYPEPTIDE SPECIES REDUCED IN CARDIOVASCULAR DISORDERS</title><source>esp@cenet</source><creator>NIKNEJAD, ANNE ; MAHE, EVE ; ROSE, KEITH ; BOUGUELERET, LYDIE ; ARGOUD-PUY, GUILAINE ; CUSIN, ISABELLE ; REFFAS, SAMIA ; BEDERR, NASSIMA ; SAUDRAIS, CEDRIC</creator><creatorcontrib>NIKNEJAD, ANNE ; MAHE, EVE ; ROSE, KEITH ; BOUGUELERET, LYDIE ; ARGOUD-PUY, GUILAINE ; CUSIN, ISABELLE ; REFFAS, SAMIA ; BEDERR, NASSIMA ; SAUDRAIS, CEDRIC</creatorcontrib><description>The invention discloses human secreted potypeptides that circulate at a decreased level in the plasma of patients with cardiovascular disorders. The invention also provides methods of using compositions including the polypeptides, polynucleotides encoding them, and antibodies specific for these polypeptides, for diagnosis, prognosis, and for drug development.
La présente invention concerne des polypeptides sécrétés humains qui circulent à un niveau réduit dans le plasma de patients atteints d'affections cardio-vasculaires. Cette invention se rapporte également à des méthodes d'utilisation de compositions comprenant les polypeptides, les polynucléotides qui les codent et les anticorps spécifiques contre ces polypeptides à des fins de diagnostic, de pronostic et pour la mise au point de médicaments.</description><edition>7</edition><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050217&DB=EPODOC&CC=WO&NR=2005014635A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050217&DB=EPODOC&CC=WO&NR=2005014635A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NIKNEJAD, ANNE</creatorcontrib><creatorcontrib>MAHE, EVE</creatorcontrib><creatorcontrib>ROSE, KEITH</creatorcontrib><creatorcontrib>BOUGUELERET, LYDIE</creatorcontrib><creatorcontrib>ARGOUD-PUY, GUILAINE</creatorcontrib><creatorcontrib>CUSIN, ISABELLE</creatorcontrib><creatorcontrib>REFFAS, SAMIA</creatorcontrib><creatorcontrib>BEDERR, NASSIMA</creatorcontrib><creatorcontrib>SAUDRAIS, CEDRIC</creatorcontrib><title>SECRETED POLYPEPTIDE SPECIES REDUCED IN CARDIOVASCULAR DISORDERS</title><description>The invention discloses human secreted potypeptides that circulate at a decreased level in the plasma of patients with cardiovascular disorders. The invention also provides methods of using compositions including the polypeptides, polynucleotides encoding them, and antibodies specific for these polypeptides, for diagnosis, prognosis, and for drug development.
La présente invention concerne des polypeptides sécrétés humains qui circulent à un niveau réduit dans le plasma de patients atteints d'affections cardio-vasculaires. Cette invention se rapporte également à des méthodes d'utilisation de compositions comprenant les polypeptides, les polynucléotides qui les codent et les anticorps spécifiques contre ces polypeptides à des fins de diagnostic, de pronostic et pour la mise au point de médicaments.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAIdnUOcg1xdVEI8PeJDHANCPF0cVUIDnB19nQNVghydQl1Bsp5-ik4Owa5ePqHOQY7h_o4Bim4eAb7B7m4BgXzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL4cH8jAwNTA0MTM2NTRyNj4lQBAHTHK8w</recordid><startdate>20050217</startdate><enddate>20050217</enddate><creator>NIKNEJAD, ANNE</creator><creator>MAHE, EVE</creator><creator>ROSE, KEITH</creator><creator>BOUGUELERET, LYDIE</creator><creator>ARGOUD-PUY, GUILAINE</creator><creator>CUSIN, ISABELLE</creator><creator>REFFAS, SAMIA</creator><creator>BEDERR, NASSIMA</creator><creator>SAUDRAIS, CEDRIC</creator><scope>EVB</scope></search><sort><creationdate>20050217</creationdate><title>SECRETED POLYPEPTIDE SPECIES REDUCED IN CARDIOVASCULAR DISORDERS</title><author>NIKNEJAD, ANNE ; MAHE, EVE ; ROSE, KEITH ; BOUGUELERET, LYDIE ; ARGOUD-PUY, GUILAINE ; CUSIN, ISABELLE ; REFFAS, SAMIA ; BEDERR, NASSIMA ; SAUDRAIS, CEDRIC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2005014635A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2005</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>NIKNEJAD, ANNE</creatorcontrib><creatorcontrib>MAHE, EVE</creatorcontrib><creatorcontrib>ROSE, KEITH</creatorcontrib><creatorcontrib>BOUGUELERET, LYDIE</creatorcontrib><creatorcontrib>ARGOUD-PUY, GUILAINE</creatorcontrib><creatorcontrib>CUSIN, ISABELLE</creatorcontrib><creatorcontrib>REFFAS, SAMIA</creatorcontrib><creatorcontrib>BEDERR, NASSIMA</creatorcontrib><creatorcontrib>SAUDRAIS, CEDRIC</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NIKNEJAD, ANNE</au><au>MAHE, EVE</au><au>ROSE, KEITH</au><au>BOUGUELERET, LYDIE</au><au>ARGOUD-PUY, GUILAINE</au><au>CUSIN, ISABELLE</au><au>REFFAS, SAMIA</au><au>BEDERR, NASSIMA</au><au>SAUDRAIS, CEDRIC</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SECRETED POLYPEPTIDE SPECIES REDUCED IN CARDIOVASCULAR DISORDERS</title><date>2005-02-17</date><risdate>2005</risdate><abstract>The invention discloses human secreted potypeptides that circulate at a decreased level in the plasma of patients with cardiovascular disorders. The invention also provides methods of using compositions including the polypeptides, polynucleotides encoding them, and antibodies specific for these polypeptides, for diagnosis, prognosis, and for drug development.
La présente invention concerne des polypeptides sécrétés humains qui circulent à un niveau réduit dans le plasma de patients atteints d'affections cardio-vasculaires. Cette invention se rapporte également à des méthodes d'utilisation de compositions comprenant les polypeptides, les polynucléotides qui les codent et les anticorps spécifiques contre ces polypeptides à des fins de diagnostic, de pronostic et pour la mise au point de médicaments.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2005014635A2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE |
| title | SECRETED POLYPEPTIDE SPECIES REDUCED IN CARDIOVASCULAR DISORDERS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T22%3A13%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NIKNEJAD,%20ANNE&rft.date=2005-02-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2005014635A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |